BioLineRx Receives Notice of Allowance From USPTO for Patent Covering BL-1020...
JERUSALEM -- BioLineRx announced today that a Notice of Allowance has been issued by the United States Patent and Trademark Office for a patent application covering the BL-1020 drug and its use for the...
View ArticleBiolinerx Receives Notice Of Allowance From Uspto For Patent Covering Bcm
BioLineRx Receives Notice Of Allowance From USPTO For Patent Covering BCM
View ArticleNew U.S. Patent for BiolineRx's BL-8040
The U.S. Patent and Trademark Office issued a new U.S. patent to BioLineRx, Ltd.'s BL-8040.
View ArticleU.S. Patent Allowance for BioLineRx' BL-8020
The U.S. Patent and Trademark Office issued a Notice of Allowance for BioLineRx, Ltd.'s BL-8020.
View Article
